Clive Wood
38Patents
18h-index
55Co-inventors
84Inventor score
Filing activity: Nov 14, 1984 → Jan 30, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4816397A | Multichain polypeptides or proteins and processes for their production | Chemistry; Metallurgy | 1,069 | Expired |
| US7488802B2 | Antibodies against PD-1 | Chemistry; Metallurgy | 392 | Expired |
| US6808710B1 | Downmodulating an immune response with multivalent antibodies to PD-1 | Physics | 278 | Expired |
| US7521051B2 | Methods of upmodulating adaptive immune response using anti-PD-1 antibodies | Chemistry; Metallurgy | 156 | Expired |
| US7101550B2 | PD-1, a receptor for B7-4, and uses therefor | Physics | 151 | Expired |
| US7105328B2 | Methods for screening for compounds that modulate pd-1 signaling | Physics | 110 | Expired |
| US7709214B2 | Methods for upregulating an immune response with agents that inhibit the intereaction between PD-L2 and PD-1 | Physics | 84 | Active |
| US5710023A | IL-13 cytokine receptor chain | Chemistry; Metallurgy | 75 | Expired |
| US7034121B2 | Antibodies against CTLA4 | Chemistry; Metallurgy | 73 | Expired |
| US8088905B2 | Nucleic acids encoding antibodies against PD-1 | Chemistry; Metallurgy | 71 | Active |
| US7638492B2 | Methods of upmodulating an immune response with non-activating forms of B7-4 | Physics | 64 | Active |
| US6004937A | Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11] | Human Necessities | 59 | Expired |
| US7432059B2 | Methods of identifying compounds that upmodulate T cell activation in the presence of a PD-1 mediated signal | Physics | 56 | Expired |
| US6664227B1 | Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains | Emerging Cross-Sectional Technologies | 33 | Expired |
| US7078494B1 | Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding | Chemistry; Metallurgy | 32 | Expired |
| US7700301B2 | Methods for screening for compounds that modulate PD-1 signaling | Physics | 30 | Active |
| US7553487B2 | Method and compositions for treating asthma | Physics | 25 | Expired |
| US7485297B2 | Method of inhibition of vascular development using an antibody | Chemistry; Metallurgy | 24 | Expired |
| US8273351B2 | Fc receptor binding proteins | Physics | 18 | Active |
| US9260520B2 | Antibodies to FeRn and uses thereof | Physics | 16 | Active |
| US8815246B2 | Fc receptor binding proteins | Physics | 15 | Active |
| US7282206B2 | Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains | Emerging Cross-Sectional Technologies | 15 | Expired |
| US7745587B2 | Antibodies that bind MMP-14 | Physics | 14 | Active |
| US6214559A | Methods of identifying inhibitors of binding of IL-13 to the IL-13 receptor chain | Chemistry; Metallurgy | 13 | Expired |
| US6248714A | Methods of inhibiting binding and treating Ig-mediated responses with IL-13 receptor | Chemistry; Metallurgy | 11 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.